(Press-News.org) There's been a breakthrough in the case of the missing planets.
While planet-hunting missions have discovered thousands of worlds orbiting distant stars, there's a severe scarcity of exoplanets that measure between 1.5 and two times Earth's radius. That's the middle ground between rocky super-Earths and larger, gas-shrouded planets called mini-Neptunes. Since discovering this 'radius gap' in 2017, scientists have been sleuthing out why there are so few midsize heavenly bodies.
The new clue arose from a fresh way of looking at the data. A team of researchers led by the Flatiron Institute's Trevor David investigated whether the radius gap changes as planets age. They divvied up exoplanets into two groups -- young and old -- and reassessed the gap. The least common planet radii from the younger set were smaller on average than the least common ones from the older set, they found. While the scarcest size for younger planets was about 1.6 times Earth's radius, it's about 1.8 times Earth's radius at older ages.
The implication, the researchers propose, is that some mini-Neptunes shrink drastically over billions of years as their atmospheres leak away, leaving behind only a solid core. By losing their gas, the mini-Neptunes "jump" the planet radius gap and become super-Earths. As time goes on, the radius gap shifts as larger and larger mini-Neptunes make the jump, transforming into larger and larger super-Earths. The gap, in other words, is the chasm between the largest-size super-Earths and the smallest-size mini-Neptunes that can still retain their atmospheres. The researchers END
Shrinking planets could explain mystery of universe's missing worlds
Studying data from the Kepler space telescope, Flatiron Institute researchers found that planetary shrinkage over billions of years likely explains a yearslong mystery: The scarcity of planets roughly double Earth's size
2021-05-17
ELSE PRESS RELEASES FROM THIS DATE:
Apixaban not superior to standard care after TAVR
2021-05-17
The blood thinner apixaban was not superior to standard of care following transcatheter aortic valve replacement (TAVR), according to findings from a new trial called ATLANTIS presented at the American College of Cardiology's 70th Annual Scientific Session. Researchers found that while apixaban reduced the formation of blood clots (thrombosis) around the implanted valve with no increased bleeding risk, a subset of patients taking apixaban who did not have an indication for anticoagulation apart from the TAVR procedure showed a tendency toward a higher rate of non-cardiovascular death--a ...
Left atrial appendage occlusion associated with low rate of stroke
2021-05-17
Transcatheter left atrial appendage occlusion (LAAO) with a WATCHMAN device was associated with a low rate of stroke at one year even among older patients with atrial fibrillation (AFib) who faced a high risk for stroke or bleeding based on their previous health history, according to new data presented at the American College of Cardiology's 70th Annual Scientific Session.
The WATCHMAN device, which blocks a small portion of the heart to help reduce the risk of a dangerous clot forming, was approved by the U.S. Food and Drug Administration in 2015. The device is used to reduce the risk of stroke in patients with AFib, a heart rhythm disorder, that is not caused by problems with the heart valve. ...
Left atrial appendage occlusion reduces stroke after heart surgery
2021-05-17
Patients with an elevated risk of stroke due to heart rhythm problems, or atrial fibrillation (AFib), were much less likely to suffer a stroke after undergoing heart surgery if doctors concurrently performed an additional procedure, called left atrial appendage occlusion (LAAO), according to the results of a trial presented at the American College of Cardiology's 70th Annual Scientific Session.
AFib increases a person's risk of stroke or systemic embolism, which are life-threatening conditions caused by blood clots blocking an artery. It has been hypothesized that the blood clots that cause these conditions often originate in the left atrial appendage, a small sac on the upper left chamber of the heart. LAAO is a procedure to ...
Sacubitril/valsartan does not outperform ACE inhibitor after heart attack
2021-05-17
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin converting enzyme (ACE) inhibitor proven effective in improving survival following heart attacks. Findings from the PARADISE-MI trial were presented at the American College of Cardiology's 70th Annual Scientific Session.
The study is the first large trial to examine whether sacubitril/valsartan can reduce heart failure and associated hospitalizations and deaths in patients post-heart attack who face a high risk of developing heart failure. Patients taking sacubitril/valsartan were about 10% less likely than those ...
Baby and regular-strength aspirin work equally well to protect heart health
2021-05-17
Researchers found no significant differences in cardiovascular events or major bleeding in patients with pre-existing cardiovascular disease who were taking 81 milligrams (mg), also called baby aspirin, versus 325 mg of daily aspirin, according to new data presented at the American College of Cardiology's 70th Annual Scientific Session.
Aspirin is the most common medication for people with established cardiovascular disease--for example, those who have had a heart attack, a stent placed or bypass surgery--to help prevent another heart attack, stroke or premature death. But despite aspirin's proven and widespread use, there has been no evidence as to whether low-dose aspirin (81 mg) or regular-strength (325 mg) aspirin is ...
Renal denervation lowers blood pressure in medication-resistant hypertension
2021-05-17
Two months after undergoing renal denervation (RDN), patients with high blood pressure who did not respond to treatment with multiple medications had a greater reduction in daytime systolic blood pressure than patients who did not receive RDN, with no difference in major adverse effects, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
Patients who received RDN--a procedure that delivers energy to overactive nerves in the kidneys to decrease their activity--saw a median reduction of 8 mmHg in their daytime ambulatory systolic blood ...
Burnout rates double for cardiology clinicians amid COVID-19
2021-05-17
The coronavirus pandemic has upended nearly every aspect of everyday life and continues to have devastating effects worldwide. It has also taken a significant toll on cardiovascular clinicians, many of whom provide direct care to patients with COVID-19, according to results of a new survey presented at the American College of Cardiology's 70th Annual Scientific Session.
Among those surveyed, burnout increased from 20% to 38% during the peak of the pandemic. Rates of burnout pre- and peak COVID-19 increased across all members of the cardiology team and was particularly striking among cardiovascular team members, ...
Clopidogrel superior to aspirin for long-term post-stent maintenance
2021-05-17
Clopidogrel outperformed aspirin in what is believed to be the first and largest randomized trial to compare the effectiveness of the two antiplatelet drugs as long-term maintenance therapy for patients who had no adverse events after one year of dual antiplatelet therapy (DAPT) following the insertion of a coronary stent. After two years of follow-up, chronic maintenance therapy with clopidogrel resulted in a 30% reduction in deaths, heart attacks, strokes or major bleeding events, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
"These data ...
No improvement in outcomes with rapid, high-sensitivity troponin T testing protocol at one year
2021-05-17
Using more sensitive and frequent repeat testing of a blood test that indicates heart injury to guide the treatment of low-risk patients with symptoms of a possible heart attack resulted in patients being discharged earlier and receiving fewer cardiac stress tests but did not improve patient outcomes after one year, according to research presented at the American College of Cardiology's 70th Annual Scientific Session. In fact, a subset of patients receiving this more sensitive and frequent blood testing protocol were more likely to have a heart attack or to die during the one-year follow-up period compared with patients whose treatment was informed by the results of conventional blood testing procedures.
Troponins are proteins found in ...
De-escalation of dual antiplatelet therapy appears safe and effective
2021-05-17
Among patients who had a cardiac stent inserted after a heart attack, switching to less-potent dual antiplatelet therapy (DAPT) after 30 days was safer and more effective in preventing adverse events a year later than continuing on a high-potency DAPT regimen, according to data presented at the American College of Cardiology's 70th Annual Scientific Session.
"We have shown that, in patients who have had a heart attack and who've been treated with newer-generation stents and guideline-recommended medical therapy, de-escalation of DAPT by switching from ticagrelor to clopidogrel is completely safe and more effective than continuing to treat patients with ticagrelor," said Kiyuk Chang, MD, professor of Cardiology, Division of Internal Medicine at the Catholic University of ...
LAST 30 PRESS RELEASES:
Fecal microbiome and bile acid profiles differ in preterm infants with parenteral nutrition-associated cholestasis
The Institute of Science and Technology Austria (ISTA) receives €5 million donation for AI research
Study finds link between colorblindness and death from bladder cancer
Tailored treatment approach shows promise for reducing suicide and self-harm risk in teens and young adults
Call for papers: AI in biochar research for sustainable land ecosystems
Methane eating microbes turn a powerful greenhouse gas into green plastics, feed, and fuel
Hidden nitrogen in China’s rice paddies could cut fertilizer use
Texas A&M researchers expose hidden risks of firefighter gear in an effort to improve safety and performance
Wood burning in homes drives dangerous air pollution in winter
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: January 23, 2026
ISSCR statement in response to new NIH policy on research using human fetal tissue (Notice NOT-OD-26-028)
Biologists and engineers follow goopy clues to plant-wilting bacteria
What do rats remember? IU research pushes the boundaries on what animal models can tell us about human memory
Frontiers Science House: did you miss it? Fresh stories from Davos – end of week wrap
Watching forests grow from space
New grounded theory reveals why hybrid delivery systems work the way they do
CDI scientist joins NIH group to improve post-stem cell transplant patient evaluation
Uncovering cancer's hidden oncRNA signatures: From discovery to liquid biopsy
Multiple maternal chronic conditions and risk of severe neonatal morbidity and mortality
Interactive virtual assistant for health promotion among older adults with type 2 diabetes
Ion accumulation in liquid–liquid phase separation regulates biomolecule localization
Hemispheric asymmetry in the genetic overlap between schizophrenia and white matter microstructure
Research Article | Evaluation of ten satellite-based and reanalysis precipitation datasets on a daily basis for Czechia (2001–2021)
Nano-immunotherapy synergizing ferroptosis and STING activation in metastatic bladder cancer
Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor
Combined aerobic-resistance exercise: Dual efficacy and efficiency for hepatic steatosis
Expert consensus outlines a standardized framework to evaluate clinical large language models
Bioengineered tissue as a revolutionary treatment for secondary lymphedema
Forty years of tracking trees reveals how global change is impacting Amazon and Andean Forest diversity
Breathing disruptions during sleep widespread in newborns with severe spina bifida
[Press-News.org] Shrinking planets could explain mystery of universe's missing worldsStudying data from the Kepler space telescope, Flatiron Institute researchers found that planetary shrinkage over billions of years likely explains a yearslong mystery: The scarcity of planets roughly double Earth's size